Peter C Gøtzsche

276.7k total citations · 32 hit papers
295 papers, 204.5k citations indexed

About

Peter C Gøtzsche is a scholar working on Statistics, Probability and Uncertainty, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Peter C Gøtzsche has authored 295 papers receiving a total of 204.5k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Statistics, Probability and Uncertainty, 57 papers in Oncology and 51 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Peter C Gøtzsche's work include Meta-analysis and systematic reviews (80 papers), Global Cancer Incidence and Screening (42 papers) and Health Systems, Economic Evaluations, Quality of Life (37 papers). Peter C Gøtzsche is often cited by papers focused on Meta-analysis and systematic reviews (80 papers), Global Cancer Incidence and Screening (42 papers) and Health Systems, Economic Evaluations, Quality of Life (37 papers). Peter C Gøtzsche collaborates with scholars based in Denmark, United Kingdom and United States. Peter C Gøtzsche's co-authors include Douglas G. Altman, Matthias Egger, Erik von Elm, Jan P. Vandenbroucke, Stuart Pocock, David Moher, Cynthia D. Mulrow, P.J. Devereaux, Jennifer Tetzlaff and John P. A. Ioannidis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Peter C Gøtzsche

287 papers receiving 201.1k citations

Hit Papers

The Cochrane Collaboration's tool for assessing ri... 2000 2026 2008 2017 2011 2009 2007 2009 2007 5.0k 10.0k 15.0k 20.0k 25.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
    2011 26.4k citations Julian P. T. Higgins, Doug Altman et al. BMJ profile →
  2. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
    2009 24.4k citations Douglas G. Altman, Cynthia D. Mulrow et al. profile →
  3. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
    2007 18.0k citations Erik von Elm, Douglas G. Altman et al. profile →
  4. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
    2009 14.6k citations Doug Altman, Cynthia D. Mulrow et al. BMJ profile →
  5. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
    2007 12.4k citations Erik von Elm, Douglas G. Altman et al. Annals of Internal Medicine profile →
  6. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    2007 11.6k citations Erik von Elm, Douglas G. Altman et al. The Lancet profile →
  7. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    2008 10.1k citations Erik von Elm, Douglas G. Altman et al. profile →
  8. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
    2009 8.8k citations Douglas G. Altman, Cynthia D. Mulrow et al. profile →
  9. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
    2009 8.4k citations Douglas G. Altman, Cynthia D. Mulrow et al. Annals of Internal Medicine profile →
  10. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
    2014 6.8k citations Erik von Elm, Douglas G. Altman et al. International Journal of Surgery profile →
  11. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
    2010 6.6k citations David Moher, Kenneth F. Schulz et al. BMJ profile →
  12. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
    2007 6.2k citations Erik von Elm, Douglas G. Altman et al. BMJ profile →
  13. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
    2007 6.1k citations Jan P. Vandenbroucke, Erik von Elm et al. profile →
  14. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
    2015 5.7k citations Cynthia D. Mulrow, Peter C Gøtzsche et al. Annals of Internal Medicine profile →
  15. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
    2013 4.4k citations Douglas G. Altman, Peter C Gøtzsche et al. Annals of Internal Medicine profile →
  16. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
    2013 3.6k citations Peter C Gøtzsche, Douglas G. Altman et al. BMJ profile →
  17. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
    2009 2.3k citations Douglas G. Altman, Cynthia D. Mulrow et al. profile →
  18. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
    2007 2.1k citations Erik von Elm, Douglas G. Altman et al. profile →
  19. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
    2007 1.9k citations Jan P. Vandenbroucke, Erik von Elm et al. Epidemiology profile →
  20. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
    2014 1.9k citations Jan P. Vandenbroucke, Erik von Elm et al. International Journal of Surgery profile →
  21. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
    2011 1.7k citations David Moher, Kenneth F. Schulz et al. International Journal of Surgery profile →
  22. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
    2010 1.4k citations David Moher, Kenneth F. Schulz et al. profile →
  23. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement
    2007 1.3k citations Erik von Elm, Douglas G. Altman et al. Epidemiology profile →
  24. Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials
    2004 1.2k citations Peter C Gøtzsche, Douglas G. Altman et al. profile →
  25. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*
    2007 1.2k citations Erik von Elm, Douglas G. Altman et al. Bulletin of the World Health Organization profile →
  26. Is the Placebo Powerless?
    2001 1.0k citations Peter C Gøtzsche et al. profile →
  27. Screening for breast cancer with mammography
    2013 980 citations Peter C Gøtzsche, Karsten Juhl Jørgensen profile →
  28. Increasing value and reducing waste: addressing inaccessible research
    2014 536 citations Tom Jefferson, Peter C Gøtzsche et al. The Lancet profile →
  29. Placebo interventions for all clinical conditions
    2010 523 citations Peter C Gøtzsche et al. profile →
  30. Is screening for breast cancer with mammography justifiable?
    2000 521 citations Peter C Gøtzsche et al. The Lancet profile →
  31. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
    2013 504 citations Douglas G. Altman, Peter C Gøtzsche et al. profile →
  32. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials
    2023 111 citations Peter C Gøtzsche, David Moher et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C Gøtzsche Denmark 74 41.2k 25.8k 25.8k 23.5k 20.1k 295 204.5k
Matthias Egger Switzerland 134 37.1k 0.9× 32.9k 1.3× 25.2k 1.0× 20.4k 0.9× 18.7k 0.9× 780 212.8k
Alessandro Liberati Italy 41 34.5k 0.8× 22.3k 0.9× 24.0k 0.9× 19.2k 0.8× 14.8k 0.7× 87 193.0k
Julian P. T. Higgins United Kingdom 118 34.4k 0.8× 23.9k 0.9× 18.9k 0.7× 23.0k 1.0× 18.8k 0.9× 471 205.3k
Jennifer Tetzlaff Canada 30 50.2k 1.2× 32.2k 1.2× 32.9k 1.3× 28.1k 1.2× 21.9k 1.1× 42 273.2k
Gordon Guyatt Canada 192 33.7k 0.8× 23.0k 0.9× 24.1k 0.9× 29.7k 1.3× 20.0k 1.0× 1.4k 174.1k
George Davey Smith United Kingdom 182 23.5k 0.6× 26.8k 1.0× 32.5k 1.3× 14.4k 0.6× 19.6k 1.0× 2.0k 218.3k
John P. A. Ioannidis United States 165 25.9k 0.6× 17.9k 0.7× 20.6k 0.8× 16.1k 0.7× 15.3k 0.8× 1.1k 189.3k
Stuart Pocock United Kingdom 117 32.9k 0.8× 16.9k 0.7× 14.4k 0.6× 16.7k 0.7× 37.0k 1.8× 582 143.9k
Mike Clarke United Kingdom 77 21.9k 0.5× 12.4k 0.5× 15.4k 0.6× 12.8k 0.5× 9.9k 0.5× 611 120.9k
Jan P. Vandenbroucke Netherlands 93 21.8k 0.5× 15.5k 0.6× 14.5k 0.6× 12.6k 0.5× 13.2k 0.7× 439 111.3k

Countries citing papers authored by Peter C Gøtzsche

Since Specialization
Citations

This map shows the geographic impact of Peter C Gøtzsche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C Gøtzsche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C Gøtzsche more than expected).

Fields of papers citing papers by Peter C Gøtzsche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C Gøtzsche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C Gøtzsche. The network helps show where Peter C Gøtzsche may publish in the future.

Co-authorship network of co-authors of Peter C Gøtzsche

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C Gøtzsche. A scholar is included among the top collaborators of Peter C Gøtzsche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C Gøtzsche. Peter C Gøtzsche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gøtzsche, Peter C & David Healy. (2022). Restoring the two pivotal fluoxetine trials in children and adolescents with depression. International Journal of Risk & Safety in Medicine. 33(4). 385–408. 2 indexed citations
2.
Jørgensen, Karsten Juhl, et al.. (2020). Suspicions of possible vaccine harms must be scrutinised openly and independently to ensure confidence. npj Vaccines. 5(1). 55–55.
3.
Jørgensen, Lars, Peter Doshi, Peter C Gøtzsche, & Tom Jefferson. (2018). Challenges of independent assessment of potential harms of HPV vaccines. BMJ. 362. k3694–k3694. 12 indexed citations
4.
Gøtzsche, Peter C, et al.. (2017). Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review. Journal of the Royal Society of Medicine. 110(10). 404–410. 53 indexed citations
5.
6.
7.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2014). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. International Journal of Surgery. 12(12). 1495–1499. 6752 indexed citations breakdown →
8.
Gøtzsche, Peter C. (2014). Why I think antidepressants cause more harm than good. The Lancet Psychiatry. 1(2). 104–106. 27 indexed citations
9.
Jørgensen, Karsten Juhl, et al.. (2013). Social ulighed i sundhed. Ugeskrift for Læger. 175(1). 74–75. 2 indexed citations
10.
Gøtzsche, Peter C, et al.. (2013). Strategies for obtaining unpublished drug trial data: a qualitative interview study. Systematic Reviews. 2(1). 31–31. 20 indexed citations
11.
Higgins, Julian P. T., Doug Altman, Peter C Gøtzsche, et al.. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 343(oct18 2). d5928–d5928. 26405 indexed citations breakdown →
12.
Gøtzsche, Peter C, Karsten Juhl Jørgensen, Per‐Henrik Zahl, & Jan Mæhlen. (2011). Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes & Control. 23(1). 15–21. 46 indexed citations
13.
Jørgensen, Karsten Juhl, et al.. (2011). Skal befolkningen tilbydes generelle helbredsundersøgelser. Ugeskrift for Læger. 173(23). 1 indexed citations
14.
Gøtzsche, Peter C. (2008). Covert duplicate publication and misleading sample size calculation: Commentary on Lee et al. (2008). International Journal of Nursing Studies. 45(9). 1398–1398.
15.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet. 370(9596). 1453–1457. 11648 indexed citations breakdown →
16.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies */Declaration De l'Initiative STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) : Recommandations Pour L'elaboration Des Rapports D'etudes Observationnelles/ Declaracion De la Iniciativa STOBE. Bulletin of the World Health Organization. 85(11). 867. 7 indexed citations
17.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Annals of Internal Medicine. 147(8). 573–577. 12444 indexed citations breakdown →
18.
Vandenbroucke, Jan P., Erik von Elm, Douglas G. Altman, et al.. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). Epidemiology. 18(6). 805–835. 1858 indexed citations breakdown →
19.
Sindet‐Pedersen, Steen, et al.. (1986). A double-blind, randomized study of naproxen and acetylsalicylic acid after surgical removal of impacted lower third molars. International Journal of Oral and Maxillofacial Surgery. 15(4). 389–394. 21 indexed citations
20.
Sindet‐Pedersen, Steen, Jens Kølsen Petersen, & Peter C Gøtzsche. (1985). Incidence ot pain conditions in dental practice in a Danisin county. Community Dentistry And Oral Epidemiology. 13(4). 244–246. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

You can learn more about the impact of Peter C Gøtzsche by visiting their Pantheon page.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthias Egger Breakdown of academic impact, for papers by Alessandro Liberati Breakdown of academic impact, for papers by Julian P. T. Higgins Breakdown of academic impact, for papers by Jennifer Tetzlaff Breakdown of academic impact, for papers by Gordon Guyatt Breakdown of academic impact, for papers by George Davey Smith Breakdown of academic impact, for papers by John P. A. Ioannidis Breakdown of academic impact, for papers by Stuart Pocock Breakdown of academic impact, for papers by Mike Clarke Breakdown of academic impact, for papers by Jan P. Vandenbroucke
Rankless by CCL
2026